Price
CHART BY
Frequently asked questions
What is AB Science's market capitalization?
The market capitalization of AB Science is 59.04M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for AB Science?
AB Science's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0392. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for AB Science's stock?
Currently, 1 analysts cover AB Science's stock, with a consensus target price of 2.70. Analyst ratings provide insights into the stock's expected performance.
What is AB Science's revenue over the trailing twelve months?
Over the trailing twelve months, AB Science reported a revenue of 1.17M.
What is the EBITDA for AB Science?
AB Science's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -4.51M. EBITDA measures the company's overall financial performance.
What is the free cash flow of AB Science?
AB Science has a free cash flow of -4.57M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does AB Science have, and what sector and industry does it belong to?
AB Science employs approximately 36 people. It operates in the Health Care sector, specifically within the Other Pharmaceuticals industry.
What is the free float of AB Science's shares?
The free float of AB Science is 65.63M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 59.04M
- EPS (TTM)
- -$0.0392
- Free Float
- 65.63M
- Revenue (TTM)
- 1.17M
- EBITDA (TTM)
- -4.51M
- Free Cashflow (TTM)
- -4.57M
Pricing
- 1D span
- $0.928$1.215
- 52W span
- $0.57$1.956
Analyst Ratings
The price target is 2.70 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
AB Science SA operates as a pharmaceutical company, which engages in the research, development, and marketing of synthetic therapeutic molecules for pathologies with high medical need, in diseases of the central nervous system, cancers, and inflammatory diseases. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.
- Employees
- 36
- Industries
- Other Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- FR0010557264
- Primary Ticker
- AB
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet